Key indicators: single-crystal X-ray study; T = 173 K; mean (C-C) = 0.002 Å; R factor = 0.038; wR factor = 0.100; data-to-parameter ratio = 25.4.
In the title compound, C 15 H 10 Cl 2 N 2 O, the dihedral angle between the mean planes of the phenyl ring and the 10-membered quinazoline ring is 63.3 (4) . In the crystal, pairs of weak C-HÁ Á ÁO interactions link the molecules into centrosymmetric dimers, forming R 2 2 (10) graph-set ring motifs. In addition, weak -stacking interactions [minimum centroidcentroid separation = 3.6810 (8) Å ] are observed, which contribute to the formation of a supramolecular assembly in the packing array.
Related literature
For general background and the pharmacological properties of quinazoline derivatives, see: Andries et al. (2005) ; AlRashood et al. (2006) ; Ghorab et al. (2010a,b,c) ; Harris & Thorarensen (2004) ; Jantova et al. (2004); Rá dl et al. (2000) ; Klepser & Klepser (1997) . For related structures, see : Brown & Gainsford (1979) ; El-Brollosy et al. (2012) ; Shi et al. (2004) ; Suguna et al. (1982) ; Xie & Li (2006) . For standard bond lengths, see: Allen et al. (1987) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). Quinazolines have been intensively studied for their interesting pharmacological properties such as anticancer activity (Ghorab et al., 2010a,b,c) . A number of quinozolines have also been clinically used as antifungal, antibacterial and antiprotozoic drugs (Jantova et al., 2004; Harris & Thorarensen, 2004) and antituberculotic agents (Andries et al., 2005) and have pharmacological properties which include antitumor (Al-Rashood et al., 2006) and analgesic (Rádl et al., 2000) properties. Dihydropyrimidine derivatives (DHPMs) may also be applied as antimicrobial, anti-inflammatory and quinazoline analogs and have showed remarkable activity against the opportunistic infections of some microorganisms proved to be the prinicipal cause of death in patients with immunocompromised diseases such as acquired immune deficiency syndrome (Klepser & Klepser, 1997 ) and fused quinazoline systems, which are also important pharmacophores. The crystal structures of some related compounds, viz., 2-phenylquinazoline 1,3-dioxide (Brown & Gainsford, 1979) (Suguna et al., 1982) and 2-diethylamino-3-phenylquinazolin-4(3H)-one (Xie et al., 2006) , have been reported. In view of the importance of the title compound, (I), C 15 H 11 Cl 2 N 2 O, this paper reports its crystal structure.
In the title compound the dihedral angle between the mean planes of the phenyl ring and the 10-membered quinazolin ring is 63.3 (4)° (Fig. 1) . Bond lengths are in normal ranges (Allen et al., 1987) . In the crystal, a weak C15-H15A···O1 intermolecular interaction link the molecules into centrosymmetric dimers forming R 2 2 (10) graph set ring motifs (Fig. 2) .
In addition, weak Cg1-Cg3 and Cg2-Cg3 π-π stacking intermolecular interactions are observed which contribute to crystal packing stability (Cg1-Cg3 = 3.6810 (8)Å; x -1/2,-y + 1/2, z -1/2; Cg2-Cg3 = 3.8821 (8)Å; x + 1/2,-y + 1/2, z -1/2; Cg1 = N(1)/C(1)/N(2)/C(2)/C(7)/C(8); Cg2 = C2-C7; Cg3 = C9-C14). No classical hydrogen bonds were found.
6-chloro-2-(chloromethyl)-3,4-dihydro-4-phenylquinazoline (10 g, 0.03434 mol) was dissolved in 40 ml of methanol and stirred for 5 mins at room temperature. To this mixture, 10 g of 50% H 2 O 2 solution (5 g, 0.147 mol) was added dropwise over 30 mins, maintaining the temperature below 313 K, then stirred for 6 hrs in a RB flask, cooled, filtered and dried at 333 K (Fig. 3) . The precipitate was dissolved in a (1:1) mixture of toluene and methylene dichloride at 313 K. After a few days, X-ray quality crystals appeared on slow evaporation.
Refinement
All of the H atoms were placed in their calculated positions and then refined using the riding model with C-H bond lengths of 0.93Å (CH) or 0.97Å (CH 2 ). Isotropic displacement parameters for these atoms were set to 1. Synthesis scheme of (I). Special details Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. 
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